CA2611577A1 - Kit et composition antibiotiques et leurs utilisations - Google Patents

Kit et composition antibiotiques et leurs utilisations Download PDF

Info

Publication number
CA2611577A1
CA2611577A1 CA002611577A CA2611577A CA2611577A1 CA 2611577 A1 CA2611577 A1 CA 2611577A1 CA 002611577 A CA002611577 A CA 002611577A CA 2611577 A CA2611577 A CA 2611577A CA 2611577 A1 CA2611577 A1 CA 2611577A1
Authority
CA
Canada
Prior art keywords
agent
acid
antibiotic
group
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002611577A
Other languages
English (en)
Inventor
Doron Friedman
Alex Besonov
Dov Tamarkin
Meir Eini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Foamix Ltd
Original Assignee
Foamix Ltd.
Doron Friedman
Alex Besonov
Dov Tamarkin
Meir Eini
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Foamix Ltd., Doron Friedman, Alex Besonov, Dov Tamarkin, Meir Eini filed Critical Foamix Ltd.
Publication of CA2611577A1 publication Critical patent/CA2611577A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
CA002611577A 2005-06-07 2006-06-07 Kit et composition antibiotiques et leurs utilisations Abandoned CA2611577A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68824405P 2005-06-07 2005-06-07
US60/688244 2005-06-07
PCT/IB2006/003975 WO2007099396A2 (fr) 2005-06-07 2006-06-07 Kit et composition antibiotiques et leurs utilisations

Publications (1)

Publication Number Publication Date
CA2611577A1 true CA2611577A1 (fr) 2007-09-07

Family

ID=38459394

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002611577A Abandoned CA2611577A1 (fr) 2005-06-07 2006-06-07 Kit et composition antibiotiques et leurs utilisations

Country Status (4)

Country Link
EP (1) EP1919449A2 (fr)
AU (1) AU2006339311A1 (fr)
CA (1) CA2611577A1 (fr)
WO (1) WO2007099396A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009124386A1 (fr) * 2008-04-07 2009-10-15 Interface Biologics Inc. Polythérapie pour le traitement des infections bactériennes

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
CA2502986C (fr) 2002-10-25 2011-08-23 Foamix Ltd. Mousse cosmetique et pharmaceutique
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
WO2008075207A2 (fr) * 2006-04-04 2008-06-26 Foamix Ltd. Composition expansible d'augmentation anti-infectieuse, et kits et utilisations de celle-ci
WO2008038140A2 (fr) * 2006-06-07 2008-04-03 Foamix Ltd. Vecteur expansible à base de polypropylène glycol et compositions pharmaceutiques associées
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
AU2008247605B2 (en) * 2007-05-04 2014-05-15 The Procter & Gamble Company Antimicrobial compositions, products, and methods of use
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (fr) 2007-11-30 2009-06-04 Foamix Ltd. Peroxyde de benzoyle contenant de la mousse
WO2009090495A2 (fr) 2007-12-07 2009-07-23 Foamix Ltd. Vecteurs moussants siliconés à base d'huile et de liquide, et formulations
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
AU2009205314A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2009103069A1 (fr) * 2008-02-15 2009-08-20 Osborne David W Système d’accentuation de la pénétration de la peau pour médicaments polaires
EP2174650A1 (fr) * 2008-10-08 2010-04-14 Polichem SA Émulsions à libération modifiée pour une application sur la peau ou la muqueuse vaginale
FR2943914A1 (fr) * 2009-04-06 2010-10-08 Fabre Pierre Dermo Cosmetique Flacon mousseur comprenant une composition pharmaceutique
CA2760186C (fr) 2009-04-28 2019-10-29 Foamix Ltd. Vehicule moussant et compositions pharmaceutiques comportant des solvants polaires aprotiques et leurs utilisations
CA2769677A1 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes a base d'agents non tensioactifs non polymeres, mousses legeres, et leurs utilisations
WO2011013009A2 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes non tensioactives, mousses légères, et leurs utilisations
CA2776366C (fr) 2009-10-02 2017-07-18 Foamix Ltd. Compositions moussantes sans eau et sans surfactant, mousses et gels friables, ainsi que leurs utilisations
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
WO2011061155A1 (fr) * 2009-11-17 2011-05-26 Bayer Consumer Care Ag Formulations antifongiques et leur utilisation
MX2012005993A (es) 2009-11-23 2012-11-23 Cubist Pharm Inc Composiciones de lipopeptido y metodos relacionados.
CN107823123A (zh) 2011-06-28 2018-03-23 化学研究有限公司 高剂量粘膜粘附甲硝唑水基凝胶制剂及其治疗细菌性***病的用途
JP6151257B2 (ja) 2011-09-09 2017-06-21 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． 肺内感染症の治療方法
US9474744B2 (en) 2011-09-21 2016-10-25 Stem Cell Medicine Ltd. Beta-lactam compounds for treating diabetes
US9345691B2 (en) 2011-09-21 2016-05-24 Stem Cell Medicine Ltd. Beta-lactam compounds for enhancing T cell-mediated immune responses
SG190466A1 (en) * 2011-11-18 2013-06-28 Agency Science Tech & Res Methods for diagnosis and/or prognosis of ovarian cancer
CN102526398A (zh) * 2012-01-17 2012-07-04 肖文辉 一种治疗慢性***的中药外用制剂
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274993A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane-tazobactam pharmaceutical compositions
EP3100732A1 (fr) 2013-03-15 2016-12-07 Merck Sharp & Dohme Corp. Compositions antibiotiques de ceftolozane
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
GB201415776D0 (en) 2014-09-05 2014-10-22 Singh Ishwar And Taylor Edward New antibacterial products
BR112017020358A2 (pt) 2015-03-23 2018-07-17 Biopharmx Inc composição farmacêutica de tetraciclina para uso dermatológico
WO2017009870A1 (fr) * 2015-07-13 2017-01-19 Ahir Pramodbhai N Formulation topique pour maladie chronique de la peau et des cheveux
CN105726545A (zh) * 2016-03-22 2016-07-06 史飞 头孢拉定通过抑制t-lak细胞起源的蛋白激酶(topk)预防和/或治疗topk活性异常增高的皮肤炎症
CN106045875A (zh) * 2016-06-25 2016-10-26 仇颖超 一种盐酸土霉素的制备方法
MX2017011630A (es) 2016-09-08 2018-09-25 Foamix Pharmaceuticals Ltd Composiciones y metodos para tratar rosacea y acne.
CA3050635A1 (fr) 2017-02-24 2018-03-01 The Regents Of The University Of California Compositions et methodes pour favoriser la pousse de cheveux avec inhibiteurs mpc
PE20200743A1 (es) 2017-06-30 2020-07-24 Univ California Composiciones y metodos para modular el crecimiento del cabello
SG11202001516QA (en) * 2017-09-29 2020-03-30 Univ California Compositions and methods for modulating hair growth
CN111920812B (zh) * 2020-07-10 2022-09-20 深圳市臻质医疗科技有限公司 一种钙通道抑制剂氧海罂粟碱在骨关节炎中的应用
CN114632075B (zh) * 2022-05-19 2022-07-15 奥信阳光(北京)药业科技有限公司 一种伏立康唑雾化吸入剂和用途
CN115463091B (zh) * 2022-10-27 2023-04-07 新基元(北京)医药科技有限公司 一种改善稳定性的米诺环素泡沫剂
CN115739051A (zh) * 2022-11-30 2023-03-07 浙江工业大学 一种疏水膜及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2502986C (fr) * 2002-10-25 2011-08-23 Foamix Ltd. Mousse cosmetique et pharmaceutique
NZ541526A (en) * 2003-01-24 2008-03-28 Stiefel Res Australia Pty Ltd Clindamycin phosphate foam
US7186416B2 (en) * 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
CA2534372C (fr) * 2003-08-04 2012-01-24 Foamix Ltd. Vehicule pour substance moussante contenant un agent gelifiant copolymere amphiphile
JP2007503428A (ja) * 2003-08-25 2007-02-22 フォーミックス エルティーディー． 浸透性医薬発泡剤

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009124386A1 (fr) * 2008-04-07 2009-10-15 Interface Biologics Inc. Polythérapie pour le traitement des infections bactériennes
US8357385B2 (en) 2008-04-07 2013-01-22 Interface Biologics Inc. Combination therapy for the treatment of bacterial infections

Also Published As

Publication number Publication date
AU2006339311A2 (en) 2007-09-07
AU2006339311A1 (en) 2007-09-07
WO2007099396A3 (fr) 2008-03-13
EP1919449A2 (fr) 2008-05-14
WO2007099396A2 (fr) 2007-09-07

Similar Documents

Publication Publication Date Title
US20190076451A1 (en) Antibiotic Kit and Composition and Uses Thereof
US9211259B2 (en) Antibiotic kit and composition and uses thereof
CA2611577A1 (fr) Kit et composition antibiotiques et leurs utilisations
US20190022000A1 (en) Anti-infection augmentation foamable compositions and kit and uses thereof
WO2008075207A2 (fr) Composition expansible d'augmentation anti-infectieuse, et kits et utilisations de celle-ci
US10588858B2 (en) Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US7645803B2 (en) Saccharide foamable compositions
US20190307685A1 (en) Nonsteroidal immunomodulating kit and composition and uses thereof
US8343945B2 (en) Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US20140182585A1 (en) Aerosol container for foamable compositions
US20070292461A1 (en) Oleaginous pharmaceutical and cosmetic foam
MX2007014106A (es) Composiciones espumables de sacarido

Legal Events

Date Code Title Description
FZDE Dead